There was no significant difference in the cumulative incidence of the primary end point at @ months between the patients in the remote ischemic preconditioning group and those in the control group ( @ patients -LSB- @ % -RSB- and @ patients -LSB- @ % -RSB- , respectively ; hazard ratio with ischemic preconditioning , @ ; @ % confidence interval , @ to @ ; P = @ ) .